Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q4 2021
Institutional positions in Verona Pharma plc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +2 vs. Q3 2021
- Shares held
- 36.9M
- −82.6K (−0.2%) vs. Q3 2021
- Total value
- $248.0M
- +$45.3M (+22.3%) vs. Q3 2021
- New holders
- 9
- 6 more added
- Sold out
- 7
- 8 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Group One Trading, L.P. | 79 | $1.00K | 0.00% | +79 | New |
| BNP Paribas Arbitrage, SA | 238 | $1.60K | 0.00% | +238 | New |
| Tower Research Capital LLC (TRC) | 333 | $2.00K | 0.00% | −1,444−81.3% | Reduced |
| CoreCap Advisors, LLC | 600 | $4.00K | 0.00% | +600 | New |
| Brewin Dolphin Ltd | 726 | $5.00K | 0.00% | −3,689−83.6% | Reduced |
| Migdal Insurance & Financial Holdings Ltd. | 826 | $6.00K | 0.00% | −498−37.6% | Reduced |
| Plante Moran Financial Advisors, LLC | 892 | $6.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 992 | $7.00K | 0.00% | −10,078−91.0% | Reduced |
| Fifth Third Bancorp | 1,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Endurance Wealth Management, Inc. | 2,000 | $13.0K | 0.00% | +2,000 | New |
| US Bancorp | 3,840 | $26.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 4,372 | $29.0K | 0.00% | +4,372 | New |
| Morgan Stanley | 7,268 | $48.0K | 0.00% | −926−11.3% | Reduced |
| Lindbrook Capital, LLC | 10,000 | $67.0K | 0.01% | +10,000 | New |
| Citadel Advisors LLC | 11,889 | $80.0K | 0.00% | −10,981−48.0% | Reduced |
| Rathbone Brothers plc | 11,959 | $80.0K | 0.00% | 00.0% | Unchanged |
| IPG Investment Advisors LLC | 11,900 | $80.0K | 0.01% | +11,900 | New |
| Marshall Wace, LLP | 12,263 | $82.0K | 0.00% | +12,263 | New |
| Geode Capital Management, LLC | 13,273 | $89.0K | 0.00% | +2,566+24.0% | Added |
| HSBC Holdings PLC | 15,041 | $102.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 15,969 | $107.0K | 0.00% | +1,183+8.0% | Added |
| Susquehanna International Group, LLP | 30,780 | $207.0K | 0.00% | +15,416+100.3% | Added |
| Forefront Analytics, LLC | 34,106 | $229.0K | 0.08% | +950+2.9% | Added |
| D.A. Davidson & Co. | 48,000 | $323.0K | 0.00% | +8,000+20.0% | Added |
| Schonfeld Strategic Advisors LLC | 58,000 | $390.0K | 0.00% | −600−1.0% | Reduced |
| Logos Global Management LP | 122,000 | $820.0K | 0.08% | +122,000 | New |
| venBio Partners LLC | 161,897 | $1.09M | 0.20% | 00.0% | Unchanged |
| Ghost Tree Capital, LLC | 750,000 | $5.04M | 1.93% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 751,905 | $5.05M | 0.16% | 00.0% | Unchanged |
| Novo Holdings A/S | 761,205 | $5.12M | 0.24% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 801,256 | $5.38M | 0.64% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 926,602 | $6.23M | 2.05% | 00.0% | Unchanged |
| Foresite Capital Management III, LLC | 1,111,112 | $7.47M | 18.90% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,111,112 | $7.47M | 1.49% | 00.0% | Unchanged |
| Aisling Capital Management LP | 1,332,485 | $8.95M | 3.16% | 00.0% | Unchanged |
| Abingworth LLP | 2,457,499 | $16.3M | 3.95% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,749,918 | $18.5M | 1.11% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 2,867,510 | $19.3M | 0.30% | −21,379−0.7% | Reduced |
| Wellington Management Group LLP | 4,831,988 | $32.5M | 0.01% | +537,950+12.5% | Added |
| Ra Capital Management, L.P. | 5,100,000 | $34.3M | 0.60% | 00.0% | Unchanged |
| NEA Management Company, LLC | 5,108,563 | $34.3M | 0.69% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,694,841 | $38.3M | 0.50% | 00.0% | Unchanged |
| Citigroup Inc | 0 | $0 | 0.00% | −495,446−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −245,594−100.0% | Sold out |
| IHT Wealth Management, LLC | 0 | $0 | 0.00% | −18,560−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −879−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −59−100.0% | Sold out |